Telomerase inhibitor
This page covers all Telomerase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Telomerase.
Targets
Phase 3 pipeline (1)
- HU-014 · Huons Co., Ltd. · Oncology
HU-014 is a synthetic oligonucleotide that acts as a telomerase inhibitor.